BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20510012)

  • 21. Syndecans play dual roles as cell adhesion receptors and docking receptors.
    Kwon MJ; Jang B; Yi JY; Han IO; Oh ES
    FEBS Lett; 2012 Jul; 586(16):2207-11. PubMed ID: 22659189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Syndecans in wound healing, inflammation and vascular biology.
    Alexopoulou AN; Multhaupt HA; Couchman JR
    Int J Biochem Cell Biol; 2007; 39(3):505-28. PubMed ID: 17097330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence of a role for a non-matrix-type metalloproteinase activity in the shedding of syndecan-1 from human myeloma cells.
    Holen I; Drury NL; Hargreaves PG; Croucher PI
    Br J Haematol; 2001 Aug; 114(2):414-21. PubMed ID: 11529866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of syndecan isoforms during mouse incisor amelogenesis.
    Muto T; Miyoshi K; Munesue S; Nakada H; Okayama M; Matsuo T; Noma T
    J Med Invest; 2007 Aug; 54(3-4):331-9. PubMed ID: 17878683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Constitutive and accelerated shedding of murine syndecan-1 is mediated by cleavage of its core protein at a specific juxtamembrane site.
    Wang Z; Götte M; Bernfield M; Reizes O
    Biochemistry; 2005 Sep; 44(37):12355-61. PubMed ID: 16156648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shed proteoglycans in tumor stroma.
    Piperigkou Z; Mohr B; Karamanos N; Götte M
    Cell Tissue Res; 2016 Sep; 365(3):643-55. PubMed ID: 27365088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anionic biopolyelectrolytes of the syndecan/perlecan superfamily: physicochemical properties and medical significance.
    Siegel G; Malmsten M; Ermilov E
    Adv Colloid Interface Sci; 2014 Mar; 205():275-318. PubMed ID: 24534475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shedding of cell membrane-bound proteoglycans.
    Nam EJ; Park PW
    Methods Mol Biol; 2012; 836():291-305. PubMed ID: 22252642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Conserved Phenylalanine in the Transmembrane Domain Enhances Heteromeric Interactions of Syndecans.
    Kwon MJ; Park J; Jang S; Eom CY; Oh ES
    J Biol Chem; 2016 Jan; 291(2):872-81. PubMed ID: 26601939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific structural features of syndecans and heparan sulfate chains are needed for cell signaling.
    Lopes CC; Dietrich CP; Nader HB
    Braz J Med Biol Res; 2006 Feb; 39(2):157-67. PubMed ID: 16470302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Syndecan, a developmentally regulated cell surface proteoglycan that binds extracellular matrix and growth factors.
    Bernfield M; Sanderson RD
    Philos Trans R Soc Lond B Biol Sci; 1990 Mar; 327(1239):171-86. PubMed ID: 1969657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mapping of matrix metalloproteinase cleavage sites on syndecan-1 and syndecan-4 ectodomains.
    Manon-Jensen T; Multhaupt HA; Couchman JR
    FEBS J; 2013 May; 280(10):2320-31. PubMed ID: 23384311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shedding light on the distinct functions of proteoglycans.
    Selleck SB
    Sci STKE; 2006 Apr; 2006(329):pe17. PubMed ID: 16595733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging Role of Syndecans in Extracellular Matrix Remodeling in Cancer.
    Jang B; Kim A; Hwang J; Song HK; Kim Y; Oh ES
    J Histochem Cytochem; 2020 Dec; 68(12):863-870. PubMed ID: 32623937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Syndecans as cell surface receptors: Unique structure equates with functional diversity.
    Choi Y; Chung H; Jung H; Couchman JR; Oh ES
    Matrix Biol; 2011 Mar; 30(2):93-9. PubMed ID: 21062643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of syndecans to lipoplex-mediated gene delivery.
    Letoha T; Kolozsi C; Ekes C; Keller-pintér A; Kusz E; Szakonyi G; Duda E; Szilák L
    Eur J Pharm Sci; 2013 Jul; 49(4):550-5. PubMed ID: 23732629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Syndecans in chronic inflammatory and autoimmune diseases: Pathological insights and therapeutic opportunities.
    Agere SA; Kim EY; Akhtar N; Ahmed S
    J Cell Physiol; 2018 Sep; 233(9):6346-6358. PubMed ID: 29226950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble syndecans: biomarkers for diseases and therapeutic options.
    Bertrand J; Bollmann M
    Br J Pharmacol; 2019 Jan; 176(1):67-81. PubMed ID: 29931674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of syndecans to cellular uptake and fibrillation of α-synuclein and tau.
    Hudák A; Kusz E; Domonkos I; Jósvay K; Kodamullil AT; Szilák L; Hofmann-Apitius M; Letoha T
    Sci Rep; 2019 Nov; 9(1):16543. PubMed ID: 31719623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth factors regulate the expression profile of their syndecan co-receptors and the differentiation of mesothelioma cells.
    Dobra K; Nurminen M; Hjerpe A
    Anticancer Res; 2003; 23(3B):2435-44. PubMed ID: 12894525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.